Alliance for Regenerative Medicine
Acronym: ARM
General Information
Identification Code: 244710319190-73
Website: [object Object]
Entity Form: Not for profit organisation registered in the US as a social welfare org. described in Internal Revenue Code (IRC) section 501(c)(4)
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 10/14/2015
Last Update: 12/21/2023
EP Accredited Number: 0
Mission & Interests
Goals: The Alliance for Regenerative Medicine (ARM, www.alliancecerm.org) is the international advocacy organization dedicated to realizing the promise of advanced therapy medicinal products (ATMPs). ARM promotes legislative, regulatory, reimbursement and manufacturing initiatives in Europe and globally to advance this innovative and transformative sector, which includes cell and gene therapies, and tissue-based therapies. ARM is the global voice of the sector, representing 400+ members worldwide, including SMEs, large companies, academic research institutions, major medical centres and patient groups.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Public health
- Research and innovation
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: ARM is interested in following any legislative or policy initiative on advanced therapies, including on broader aspects which may have an impact on advanced therapies such as initiatives on pharmaceuticals, blood, tissues and cells, clinical trials, orphan medicines, health technology assessment, health data, cross-border healthcare. ARM is also interested in initiatives and policy developments relating to small and medium size enterprises and access to capital.
Communication Activities: As part of its activities, ARM releases policy recommendations, policy papers and reports. ARM produces regular reports providing an overview of the sector including data on clinical trial, therapeutic developers and investment in the sector. ARM also publishes a newsletter for its members where regulatory, legislative and policy developments in Europe and elsewhere are reported. ARM organizes an annual meeting on advanced therapies in Europe, named the Cell & Gene Meeting on the Mediterranean. See more on www.alliancerm.org
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 1015 18th Street NWSuite 1102
Post Code: 20036
City: Washington DC
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: Rue de L'Industrie 24
Post Code: 1040
City: Brussels
Country: BELGIUM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 0
Members25 Percent: 2
Members50 Percent: 1
Members75 Percent: 0
Members: 4
Members F T E: 2
Structure
Structure Type: Structure
Is Member Of: ARM members are over 400 and include public and private companies (the majority of which are small- and medium-size enterprises), research institutions, investors, patient advocates/foundations and associations, affiliate members.
See list on https://alliancerm.org/members/members-and-profiles/
Organisation Members: Standards Coordinating Body for Gene, Cell and Regenerative Medicines and Cell-Based Drug Discovery
Foundation for Cell and Gene Medicine
National Academy of Sciences Forum on Regenerative Medicine